Study to improve atrial fibrillation ablation and new therapies
Part of Heart & circulation clinical trials.
This study looks at what results from atrial fibrillation ablation (a heart rhythm procedure) and newer related therapies. If you recently had the procedure—or are scheduled for it soon—you may use an app and website to share information that helps researchers compare outcomes and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an adult age 18 or older
- Have a smartphone (iOS or Android) and a working cell phone number
- Be willing to download the study’s Eureka Research Platform app
- Have an email address and be able to use the study website on a phone or computer
- Have had atrial fibrillation catheter ablation within the past week, or have it planned within the next week
- Be able to consent for yourself and read/speak/comprehend English
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different computer “analysis methods” that look at real-time heart recordings from people with atrial fibrillation. It may help improve how atrial fibrillation is evaluated during/after an ablation procedure.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
This study tracks results after a heart ablation procedure used to treat atrial fibrillation (an irregular heart rhythm). You may be asked to help by consenting and following the study plan so the researchers can better understand what happens after ablations.
This study is a registry that collects information from patients with atrial fibrillation who are having an ablation procedure. It aims to improve care and research by tracking outcomes. You may be able to join if you are scheduled for an ablation, and some participants may be asked to take part in additional optional sub-studies.
This study tests a new device (FARAFLEX) that uses pulsed field energy to treat atrial fibrillation (AFib). You may qualify if you have persistent or paroxysmal AFib symptoms and have not had a prior ablation.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.